A group of researchers in Trondheim, Norway, are the first in the world to use in vivo magnetic resonance spectroscopy (MRS) to separate benign tumors from cancer. Ingrid Susann Gribbestad shows, in her recently published thesis, how one can discover breast cancer and monitor the treatment by using this new technology. The work is financed by the Norwegian Cancer Society and the Research Council of Norway.
The above story is based on materials provided by Norwegian Cancer Society. Note: Materials may be edited for content and length.
Cite This Page:
Norwegian Cancer Society. "New Technology Separates Cancer From Benign Tumors." ScienceDaily. ScienceDaily, 4 November 2002. <www.sciencedaily.com/releases/2002/11/021104063612.htm>.
Norwegian Cancer Society. (2002, November 4). New Technology Separates Cancer From Benign Tumors. ScienceDaily. Retrieved April 25, 2014 from www.sciencedaily.com/releases/2002/11/021104063612.htm
Norwegian Cancer Society. "New Technology Separates Cancer From Benign Tumors." ScienceDaily. www.sciencedaily.com/releases/2002/11/021104063612.htm (accessed April 25, 2014).